Concurrent delivery of immune checkpoint blockade modulates T cell dynamics to enhance neoantigen vaccine-generated anti-tumor immunity

Neoantigen vaccines aiming to induce tumor-specific T cell responses have achieved promising anti-tumor effects in early clinical trials. However, the underlying mechanism regarding response or resistance to this treatment remains unclear. Here, we observe that neoantigen vaccine-generated T cells c...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Longchao, Chen, Jiahui, Zhang, Hongyi, Ye, Jianfeng, Moore, Casey, Lu, Changzheng, Fang, Yan, Fu, Yang-Xin, Li, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050907/
https://www.ncbi.nlm.nih.gov/pubmed/35393580
http://dx.doi.org/10.1038/s43018-022-00352-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050907/
https://www.ncbi.nlm.nih.gov/pubmed/35393580
http://dx.doi.org/10.1038/s43018-022-00352-7

Ejemplares similares